Q3 2022 Holdings
Filed 2022-10-21 | 465 holdings | $46.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verve Therapeutics Inc | Common Stock | 92539P101 | $19 | 561 | 0.0% |
| Fate Therapeutics Inc(FATE) | Common Stock | 31189P102 | $20 | 909 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common Stock | 46583P102 | $20 | 1,106 | 0.0% |
| Legend Biotech Corp(LEGN) | ADR | 52490G102 | $20 | 499 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common Stock | 98420N105 | $21 | 583 | 0.0% |
| Edwards Lifesciences Corp(EW) | Common Stock | 28176E108 | $21 | 256 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $22 | 650 | 0.0% |
| Sage Therapeutics Inc(SG7) | Common Stock | 78667J108 | $22 | 556 | 0.0% |
| Relay Therapeutics Inc(RLAY) | Common Stock | 75943R102 | $23 | 1,020 | 0.0% |
| Pacira Biosciences Inc(PCRX) | Common Stock | 695127100 | $23 | 429 | 0.0% |
| Prometheus Biosciences Inc | Common Stock | 74349U108 | $23 | 383 | 0.0% |
| Insmed Inc(INSM) | Common Stock | 457669307 | $24 | 1,124 | 0.0% |
| VIR Biotechnology Inc(VIR) | Common Stock | 92764N102 | $24 | 1,242 | 0.0% |
| Harmony Biosciences Holdings(HRMY) | Common Stock | 413197104 | $25 | 554 | 0.0% |
| Abcellera Biologics Inc(ABCL) | Common Stock | 00288U106 | $26 | 2,670 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common Stock | 03152W109 | $27 | 2,627 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | Common Stock | 90400D108 | $27 | 656 | 0.0% |
| Prothena Corp PLC(PRTA) | Common Stock | G72800108 | $27 | 439 | 0.0% |
| Maravai Lifesciences Hldgs(MRVI) | Common Stock | 56600D107 | $31 | 1,232 | 0.0% |
| Alkermes PLC(ALKS) | Common Stock | G01767105 | $34 | 1,538 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common Stock | 69366J200 | $34 | 670 | 0.0% |
| Staar Surgical Co(STAA) | Common Stock | 852312305 | $35 | 496 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | Common Stock | 16383L106 | $35 | 673 | 0.0% |
| Denali Therapeutics Inc(DNLI) | Common Stock | 24823R105 | $35 | 1,155 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common Stock | 60468T105 | $36 | 521 | 0.0% |
| Blueprint Medicines Corp(2L9) | Common Stock | 09627Y109 | $37 | 559 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | Common Stock | 46116X101 | $41 | 884 | 0.0% |
| Global Blood Therapeutics in | Common Stock | 37890U108 | $43 | 632 | 0.0% |
| Syneos Health Inc(8IN) | Common Stock | 87166B102 | $45 | 961 | 0.0% |
| Medpace Holdings Inc(MEDP) | Common Stock | 58506Q109 | $46 | 290 | 0.0% |
| Exelixis Inc(EXEL) | Common Stock | 30161Q104 | $47 | 3,014 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | Common Stock | 45826J105 | $48 | 866 | 0.0% |
| Xpeng Inc(XPEV) | ADR | 98422D105 | $57 | 4,800 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | Common Stock | 462222100 | $59 | 1,329 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | Common Stock | 03753U106 | $70 | 1,029 | 0.0% |
| Karuna Therapeutics Inc | Common Stock | 48576A100 | $72 | 318 | 0.0% |
| Novocure LTD(NVCR) | Common Stock | G6674U108 | $75 | 981 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | Common Stock | G50871105 | $78 | 587 | 0.0% |
| United Therapeutics Corp(UTHR) | Common Stock | 91307C102 | $89 | 426 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common Stock | 803607100 | $91 | 820 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | Common Stock | 64125C109 | $95 | 896 | 0.0% |
| General Motors Co(GM) | Common Stock | 37045V100 | $96 | 3,000 | 0.0% |
| Viatris Inc(VTRS) | Common Stock | 92556V106 | $97 | 11,355 | 0.0% |
| Sanofi(SNY) | ADR | 80105N105 | $104 | 2,724 | 0.0% |
| Qualcomm Inc(QCOM) | Common Stock | 747525103 | $113 | 1,000 | 0.0% |
| Guardant Health Inc(GH) | Common Stock | 40131M109 | $127 | 2,352 | 0.0% |
| Consumer Discretionary Selt(XLY) | ETP | 81369Y407 | $128 | 900 | 0.0% |
| Horizon Therapeutics PLC | Common Stock | G46188101 | $133 | 2,157 | 0.0% |
| Incyte Corp(INCY) | Common Stock | 45337C102 | $139 | 2,083 | 0.0% |
| Zoetis Inc(ZTS) | Common Stock | 98978V103 | $146 | 986 | 0.0% |